All Stories

  1. Impact of deep-freezing on the nutrient profile of fish and seafood mostly consumed in Italy
  2. Object‐Control Skills and Cortisol Response During Physical Education Lessons in Primary School Children
  3. Skeletal Muscle Effects of GLP 1 Receptor Agonists: Molecular Mechanisms and Comparative Insights on Semaglutide and Tirzepatide, a Narrative Review
  4. Association of Mediterranean Diet Adherence with Self-Reported Muscle-Related Functional Status and Fracture Probability in Postmenopausal Women Evaluated for Osteoporosis: A Cross-Sectional Study
  5. Psychometric Properties of the Italian Food Noise Questionnaire (FNQ) for the Assessment of Intrusive Food-Related Thoughts
  6. Long-Term Effects of a Multidisciplinary School-Based Intervention on Children’s Healthy Habits: A 1-Year Follow-Up
  7. Ovarian Neuroendocrine Neoplasms: Challenges and Future Perspectives
  8. Dietary Approaches in the Management of Adrenoleukodystrophy: Evidence Summary for Nutritional Tips
  9. An Integrated Nutritional and Physical Activity Approach for Osteosarcopenia
  10. Evaluation of the Influence of Intervention Tools Used in Nutrition Education Programs: A Mixed Approach
  11. HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations
  12. Toward Multidimensional Front-of-Pack Labels: Integrating Nutritional, Environmental, and Processing Information
  13. Male osteoporosis: the impact of lifestyle, from nutrition to physical activity
  14. Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice
  15. Nutrition, Vitamin D, and Calcium in Elderly Patients before and after a Hip Fracture and Their Impact on the Musculoskeletal System: A Narrative Review
  16. Vitamin D as a Shield against Aging
  17. Gluten-Free Diet and Metabolic Syndrome: Could Be a Not Benevolent Encounter?
  18. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food
  19. Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients
  20. Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic literature review
  21. Nutritional and physical activity issues in frailty syndrome during the COVID-19 pandemic
  22. Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations
  23. Environmental Contaminants Acting as Endocrine Disruptors Modulate Atherogenic Processes: New Risk Factors for Cardiovascular Diseases in Women?
  24. Nutrition and Physical Activity-Induced Changes in Gut Microbiota: Possible Implications for Human Health and Athletic Performance
  25. Environmental Contaminants Acting as Endocrine Disruptors Modulate Atherogenic Processes: New Risk Factors for Cardiovascular Diseases in Women?
  26. Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study
  27. The endocrine disruptor cadmium: a new player in the pathophysiology of metabolic diseases
  28. Phosphodiesterase Type-5 Inhibitor Tadalafil Modulates Steroid Hormones Signaling in a Prostate Cancer Cell Line
  29. Dietary Calcium Intake in a Cohort of Individuals Evaluated for Low Bone Mineral Density: a Multicenter Italian Study
  30. MicroRNA Modulation by Dietary Supplements in Obesity
  31. Tissue and circulating microRNAs as biomarkers of response to obesity treatment strategies
  32. Circulating Long Non-Coding RNA GAS5 Is Overexpressed in Serum from Osteoporotic Patients and Is Associated with Increased Risk of Bone Fragility
  33. Can Haematological and Hormonal Biomarkers Predict Fitness Parameters in Youth Soccer Players? A Pilot Study
  34. Dietary Calcium Intake in a Cohort of Individuals Evaluated for Low Bone Mineral Density: A Multicentre Italian Study
  35. <p>Multifactorial Assessment of Risk of Falling in 753 Post-Menopausal Women: A Multicenter Cross-Sectional Study by the Italian Group for the Study of Metabolic Bone Diseases</p>
  36. Do Dietary Supplements and Nutraceuticals Have Effects on Dental Implant Osseointegration? A Scoping Review
  37. Effects of Acute Whole-Body Vibration Practice on Maximal Fat Oxidation in Adult Obese Males: A Pilot Study
  38. Effect of pre-season training phase on anthropometric, hormonal and fitness parameters in young soccer players
  39. Role of vitamin K2 in bone metabolism: a point of view and a short reappraisal of the literature
  40. Epigenetic Modifications Induced by Nutrients in Early Life Phases: Gender Differences in Metabolic Alteration in Adulthood
  41. Energy Balance and Active Lifestyle: Potential Mediators of Health and Quality of Life Perception in Aging
  42. Role of Hypovitaminosis D in the Pathogenesis of Obesity-Induced Insulin Resistance
  43. Characterization of the Effects of a Six-Month Dancing as Approach for Successful Aging
  44. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
  45. Retrospective evaluation of persistence in osteoporosis therapy with oral bisphosphonates in Italy: the TOBI study
  46. Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
  47. Relationship between individual ventilatory threshold and maximal fat oxidation (MFO) over different obesity classes in women
  48. Effects of body weight loss program on parameters of muscle performance in female obese adults
  49. Response to: Comment #2 on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
  50. Correction to: Cadmium exposure alters steroid receptors and proinflammatory cytokine levels in endothelial cells in vitro: a potential mechanism of endocrine disruptor atherogenic effect
  51. Effects of essential amino acid supplementation and rehabilitation on functioning in hip fracture patients: a pilot randomized controlled trial
  52. Cadmium exposure alters steroid receptors and proinflammatory cytokine levels in endothelial cells in vitro: a potential mechanism of endocrine disruptor atherogenic effect
  53. Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO
  54. Guidelines for the management of osteoporosis and fragility fractures
  55. Prediction equation to estimate heart rate at individual ventilatory threshold in female and male obese adults
  56. HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy
  57. Functional determinants of dietary intake in community-dwelling older adults: a DEDIPAC (DEterminants of DIet and Physical ACtivity) systematic literature review
  58. Multidisciplinary Approach to Osteoporosis
  59. Effects of an individualized home-based unsupervised aerobic training on body composition and physiological parameters in obese adults are independent of gender
  60. The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism
  61. Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy
  62. Alterations of functional connectivity of the motor cortex in Fabry disease
  63. Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis
  64. Insulin growth factor-1 correlates with higher bone mineral density and lower inflammation status in obese adult subjects
  65. Potential role for the VDR agonist elocalcitol in metabolic control: Evidences in human skeletal muscle cells
  66. Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro characterization
  67. Response to: Comment on “Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects”
  68. Validation of the Italian version of the Laval questionnaire: health-related quality of life in subjects with obesity
  69. Physical activity and hypocaloric diet recovers osteoblasts homeostasis in women affected by abdominal obesity
  70. Disability, Physical Inactivity, and Impaired Health-Related Quality of Life Are Not Different in Metabolically Healthy vs. Unhealthy Obese Subjects
  71. Using concept mapping in the development of the EU-PAD framework (EUropean-Physical Activity Determinants across the life course): a DEDIPAC-study
  72. Are dietary supplements and nutraceuticals effective for musculoskeletal health and cognitive function? A scoping review
  73. Critical review of the equations predicting 6-minute walking distance in obese subjects
  74. Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy
  75. Effects of combined physical education and nutritional programs on schoolchildren’s healthy habits
  76. Reduced sleep duration affects body composition, dietary intake and quality of life in obese subjects
  77. Assessment of trabecular bone score (TBS) in overweight/obese men: effect of metabolic and anthropometric factors
  78. The pathophysiological basis of bone tissue alterations associated with eating disorders
  79. Differences in Ventilatory Threshold for Exercise Prescription in Outpatient Diabetic and Sarcopenic Obese Subjects
  80. The obesity of bone
  81. The endocrine disruptor cadmium alters human osteoblast-like Saos-2 cells homeostasis in vitro by alteration of Wnt/β-catenin pathway and activation of caspases
  82. Prevalent fragility fractures as risk factor for skeletal muscle function deficit and dysmobility syndrome in post-menopausal women
  83. Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model
  84. Osso e infiammazione
  85. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism
  86. Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
  87. Multidisciplinary Approach to Obesity
  88. Effects of Aerobic Exercise Based upon Heart Rate at Aerobic Threshold in Obese Elderly Subjects with Type 2 Diabetes
  89. P148: La fonction physique, le niveau d’activité physique et d’autonomie chez des femmes obèses et sarcopéniques pré-gériatriques
  90. Lean mass in obese adult subjects correlates with higher levels of vitamin D, insulin sensitivity and lower inflammation
  91. Obesity and Osteoporosis
  92. Sarcopenic Obesity
  93. Interdisciplinary Approach to Obesity
  94. Ovarian Function and Obesity: PCOS, Menopause
  95. Age-associated (cardio)metabolic diseases and cross-talk between adipose tissue and skeleton: endocrine aspects
  96. P354: Obesity: body composition and functional parameters
  97. The environmental pollutant cadmium induces homeostasis alteration in muscle cells in vitro
  98. Vγ9 Vδ2 T lymphocytes activation as a novel approach to test efficacy of different bisphosphonates
  99. Psoriasis and bone mineral density: Implications for long‐term patients
  100. Treatment of body composition changes in obese and overweight older adults: insight into the phenotype of sarcopenic obesity
  101. La distalizzazione ottenuta con il pendulum di Hilgers: revisione della letteratura
  102. Analysis of human alveolar osteoblast behavior on a nano-hydroxyapatite substrate: an in vitro study
  103. Obesity treatment: results after 4 years of a Nutritional and Psycho-Physical Rehabilitation Program in an outpatient setting
  104. Habitual fish intake and clinically silent carotid atherosclerosis
  105. Adipose, bone and muscle tissues as new endocrine organs: role of reciprocal regulation for osteoporosis and obesity development
  106. Abdominal Fat and Sarcopenia in Women Significantly Alter Osteoblasts HomeostasisIn Vitroby a WNT/β-Catenin Dependent Mechanism
  107. Health-Related Quality of Life and Quality of Sexual Life in Obese Subjects
  108. Sarcopenic Obesity: Correlation with Clinical, Functional, and Psychological Status in a Rehabilitation Setting
  109. Nutrition and Growth
  110. Arterial aneurysms: autosomal dominant polycystic kidney disease, Marfan syndrome or both?
  111. Skeletal alterations in women affected by obesity
  112. New therapeutical horizons in the management of postmenopausal osteoporosis
  113. Body composition in sarcopenic obesity: systematic review of the literature
  114. Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study
  115. Physical exercise intensity prescription to improve health and fitness in overweight and obese subjects: A review of the literature
  116. Trunk Fat Negatively Influences Skeletal and Testicular Functions in Obese Men: Clinical Implications for the Aging Male
  117. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study
  118. Concerns About Serum Androgens Monitoring During Testosterone Replacement Treatments in Hypogonadal Male Athletes: A Pilot Study
  119. Is obesity in women protective against osteoporosis?
  120. Guidelines for the diagnosis, prevention and treatment of osteoporosis
  121. Evaluation of adherence and persistence to teriparatide treatment in patients affected by severe osteoporosis: A multicenter observational real life study
  122. Effects of an Upper Body High Intensity Interval Training on Body Composition
  123. Differential characteristics of bone quality and bone turnover biochemical markers in patients with hip Fragility Fractures and Hip Osteoarthritis: results of a clinical pilot study
  124. Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro
  125. The Role of Steroids in Endothelial Function in the Aging Male
  126. Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index
  127. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors
  128. The Role of Steroids in Endothelial Function in the Ageing Male
  129. Approach in glucocorticoid-induced osteoporosis prevention: The EGEO study preliminary data
  130. Management of glucocorticoids-induced osteoporosis: role of teriparatide
  131. Impairment of diastolic function in adult patients affected by osteogenesis imperfecta clinically asymptomatic for cardiac disease: Casuality or causality?
  132. SERMs
  133. Characterization of bone mineral density in male-to-female transsexuals receiving treatment for reassignment surgery: 15 years of follow-up
  134. A New Heterozygous Mutation (R714C) of the Osteopetrosis Gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), Impairs Vesicular Acidification and Increases TRACP Secretion in Osteoclasts
  135. Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment
  136. The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
  137. Effect of titanium carbide coating on the osseointegration response in vitro and in vivo
  138. Cadmium induces mitogenic signaling in breast cancer cell by an ERα-dependent mechanism
  139. Modulation of human estrogen receptor α F promoter by a protein kinase C/c-Src-dependent mechanism in osteoblast-like cells
  140. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment
  141. Raloxifene Modulates Interleukin-6 and Tumor Necrosis Factor-α Synthesisin Vivo: Results from a Pilot Clinical Study
  142. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up
  143. In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells
  144. Imbalance of Osteoclastogenesis-Regulating Factors in Patients With Celiac Disease
  145. Interaction of estrogen receptor α with protein kinase C α and c-Src in osteoblasts during differentiation
  146. Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway
  147. Type II Benign Osteopetrosis (Albers-Schönberg Disease) Caused by a Novel Mutation in CLCN7 Presenting with Unusual Clinical Manifestations
  148. Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro
  149. Isoflavones and skeletal health: are these molecules ready for clinical application?
  150. Estrogens and Estrogen Receptors: New Actors in the Plot of Transcriptional Regulation of Genomic Responses
  151. Genotype-Phenotype Relationship in Human ATP6i-Dependent Autosomal Recessive Osteopetrosis
  152. The Role of the AlphaVbeta3 Integrin in the Development of Osteolytic Bone Metastases: A Pharmacological Target for Alternative Therapy?
  153. The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro
  154. Characterization of the osteoblast‐like cell phenotype under microgravity conditions in the NASA‐approved rotating wall vessel bioreactor (RWV)
  155. Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved rotating wall vessel bioreactor (RWV)
  156. Apparent Cure of a Newborn with Malignant Osteopetrosis Using Prednisone Therapy
  157. Reduced Growth and Skeletal Changes in Zinc-Deficient Growing Rats Are Due to Impaired Growth Plate Activity and Inanition
  158. Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines
  159. Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation
  160. Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood
  161. Mechanisms of Osteoclast Dysfunction in Human Osteopetrosis: Abnormal Osteoclastogenesis and Lack of Osteoclast-Specific Adhesion Structures
  162. Osteoclast Isolation: New Developments and Methods
  163. Association of Intermediate Osteopetrosis with Poikiloderma
  164. Decreased Proliferation and Altered Differentiation in Osteoblasts from Genetically and Clinically Distinct Craniosynostotic Disorders
  165. A Novel Calcium Sensor Stimulating Inositol Phosphate Formation and [Ca2+]i Signaling Expressed by GCT23 Osteoclast‐Like Cells
  166. Modulation of Estrogen Receptor Levels in Mouse Uterus by Protein Kinase C Isoenzymes1
  167. Modulation of Estrogen Receptor Levels in Mouse Uterus by Protein Kinase C Isoenzymes
  168. Phospholipase D- and Protein Kinase C Isoenzyme-Dependent Signal Transduction Pathways Activated by the Calcitonin Receptor1
  169. Protein Kinase C Modulates Estrogen Receptors in Differentiated Osteoblastic Cells In Vitro
  170. Colony Stimulating Factor-1–Induced Osteoclast Spreading Depends on Substrate and Requires the Vitronectin Receptor and the c-src Proto-Oncogene
  171. Transforming growth factor-β enhances adhesion of melanoma cells to the endotheliumin vitro
  172. Transforming growth factor‐β enhances adhesion of melanoma cells to the endothelium in vitro
  173. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring.
  174. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring
  175. Alterations in estrogen levels during development affects the skeleton: use of an animal model.
  176. Alterations in Estrogen Levels during Development Affects the Skeleton: Use of an Animal Model
  177. Endogenous protein kinase-C activation in osteoblast-like cells modulates responsiveness to estrogen and estrogen receptor levels
  178. Endogenous protein kinase-C activation in osteoblast-like cells modulates responsiveness to estrogen and estrogen receptor levels.
  179. Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor
  180. Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor.
  181. Short-term exposure of developing female mice to diethylstilbestrol increases bone density in adulthood
  182. Developmental exposure to estrogens induces persistent changes in skeletal tissue.
  183. Developmental exposure to estrogens induces persistent changes in skeletal tissue
  184. Long Term Treatment with Adenosine Analogs Modifies the Responsiveness of Immature Rat Sertoli Cell in Culture*
  185. A Novel Melatonin Antagonist, N-(2,4-Dinitrophenyl)-5-Methoxytryptamine Neutralizes Some Effects of Melatonin in the Female Syrian Hamster
  186. Characterization and Function of Adenosine Receptors in the Testisa
  187. Rate of reproductive involution following either exposure to short days or daily administration of melatonin is faster in inbred than in random-bred female Syrian hamsters